Related Experiment Video
Updated: Jun 30, 2025

Chronic Salmonella Infection Induced Intestinal Fibrosis
Published on: September 22, 2019
Gastrointestinal histoplasmosis with small intestinal perforation: 20-year experience
Jack W Sample1, Jennifer A Yonkus2, Maxwell D Mirande2
1Department of Surgery, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA. sample.jack@mayo.edu.
Abstract:
Postmortem studies show gastrointestinal tract involvement in as many as 70% of patients affected by disseminated histoplasmosis. Although gastrointestinal involvement is common in disseminated disease, the presentation of small intestinal perforation is exceedingly rare with few reported cases in the literature. Herein we present our institutional case series. The aim of the study is to describe small intestinal perforation in gastrointestinal histoplasmosis with attention to management and outcomes. This is a retrospective single-institution review of patients ≥ 18 years of age treated for small intestinal perforation due to gastrointestinal histoplasmosis. A prospectively maintained institutional database was searched from 2002 to 2022. Data obtained included demographics, comorbidities, treatment course, and outcomes. Five patients with a mean age of 54 years (range 25-72) were identified. Pertinent underlying comorbid conditions included Crohn's disease, psoriatic arthritis, rheumatoid arthritis, and solid organ transplantation. All patients were on chronic immunosuppressive medication(s) with the most common being tumor necrosis factors alpha inhibitors and corticosteroids. Four had a clinical diagnosis of perforation based on physical examination and imaging. All patients underwent segmental resection(s) of the small intestine and received medical treatment with intravenous amphotericin B and eventual transition to an oral antifungal. No patients experienced complications related to surgery. The limitations of the study include nonrandomized retrospective review, single-institution experience, and small patient sample size. Although rare, histoplasmosis should be considered in the differential of patients on chronic immunosuppressive therapy who present with gastrointestinal symptoms concerning perforation, especially from endemic areas. Small intestinal perforation due to gastrointestinal histoplasmosis can be successfully treated with resection and antifungal therapy.
Insights
Small intestinal perforation is a rare complication of gastrointestinal histoplasmosis, particularly in immunocompromised patients. Surgical resection and antifungal therapy offer successful treatment outcomes for this serious condition.
Area of Science:
- Gastroenterology
- Infectious Diseases
- Surgical Pathology
Background:
- Gastrointestinal tract involvement is common in disseminated histoplasmosis, affecting up to 70% of patients.
- Small intestinal perforation is an exceedingly rare presentation of gastrointestinal histoplasmosis.
Purpose of the Study:
- To describe the clinical presentation, management, and outcomes of small intestinal perforation in patients with gastrointestinal histoplasmosis.
- To highlight the importance of considering histoplasmosis in the differential diagnosis of gastrointestinal perforation in immunocompromised individuals.
Main Methods:
- Retrospective review of a single-institution case series from 2002 to 2022.
- Inclusion criteria: patients ≥18 years old treated for small intestinal perforation due to gastrointestinal histoplasmosis.
- Data collected: demographics, comorbidities, treatment, and outcomes.
Main Results:
- Five patients (mean age 54 years) with underlying conditions like Crohn's disease and solid organ transplantation were identified.
- All patients were on chronic immunosuppressive medications, including TNF-alpha inhibitors and corticosteroids.
- All patients underwent small intestinal resection and received antifungal therapy (amphotericin B followed by oral antifungals) with no surgical complications.
Conclusions:
- Histoplasmosis should be considered in the differential diagnosis of gastrointestinal perforation in patients on immunosuppressive therapy, especially in endemic areas.
- Small intestinal perforation due to gastrointestinal histoplasmosis is treatable with surgical resection and antifungal therapy.
Related Concept Videos
Esophageal Perforation-II: Clinical Manifestations and Management
Clinical Manifestations:
Esophageal Perforation-I: Introduction
The location of esophageal perforation can vary, occurring anywhere along the esophagus....
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:

